The Mpox Vaccine Hesitancy Scale for Mpox: Links with Vaccination Intention among Men Who Have Sex with Men in Six Cities of China

Author:

Gao Ying1ORCID,Liu Shangbin1,Xu Huifang12,Wang Ying1,Xu Gang2,Hu Fan1,Zhang Jiechen3,Cai Yong1

Affiliation:

1. Public Health Department, Hongqiao International Institute of Medicine, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China

2. School of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China

3. Dermatology Department, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China

Abstract

Background: Vaccine hesitancy is a significant barrier to achieving high vaccination rates, particularly among men who have sex with men (MSM), a group at increased risk for Mpox. This study aimed to develop and validate a Mpox vaccine hesitancy scale specifically tailored for Chinese MSM, grounded in the protection motivation theory (PMT). Methods: An online survey through snowball sampling was conducted from October 2023 to March 2024, collecting 2403 valid responses across six representative regions in China. Exploratory factor analysis (EFA) and confirmatory factor analysis (CFA) were conducted to evaluate the scale’s construct validity, while reliability was assessed using Cronbach’s α coefficient. The predictive validity of the scale was analyzed using Receiver Operating Characteristic (ROC) analysis. Results: EFA ultimately retained 22 items in the Mpox vaccination scale and identified four distinct dimensions: Maladaptive Rewards (seven items), Self-efficacy (seven items), Response Efficacy (four items), and Response Costs (four items). These dimensions were confirmed by CFA, which demonstrated satisfactory model fit indices (χ²/df = 4.382, RMSEA = 0.053, SRMR = 0.048, GFI = 0.935, CFI = 0.967, NFI = 0.958, TLI = 0.963, and IFI =0.967). All indices were within acceptable ranges. The scale exhibited good internal consistency, with a Cronbach’s alpha of 0.906, and strong content validity, with an S-CVI/Ave of 0.952. The scale’s predictive accuracy was evaluated using Receiver Operating Characteristic (ROC) analysis. When used to evaluate the scale’s predictive accuracy, it yielded an area under the curve (AUC) of 0.854 after adjustments, indicating good predictive ability between high and low hesitancy. Conclusions: This scale provides a reliable and valid tool for assessing Mpox vaccine hesitancy among MSM and can be used to gauge Mpox vaccination intention within this group.

Funder

Key discipline projects of Shanghai Three-Year Action Plan for Public Health

national health commission of the PRC

Science and Technology Commission Shanghai Municipality

Key Populations, Tongren Hospital Talent Launch Project

Changning District Medical and Health Research Special Project

Shanghai Tongren Hospital, Shanghai Jiaotong University School of Medicine

Publisher

MDPI AG

Reference45 articles.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3